comparemela.com

Latest Breaking News On - Sophia bashford - Page 1 : comparemela.com

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Schopfheim
Baden-wüberg
Germany
Australia
Munich
Bayern
Czech-republic
Boston
Massachusetts
United-states
South-africa

Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression

Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Czech-republic
Munich
Bayern
Germany
Pratteln
Switzerland-general
Switzerland
Australia
Poland
Schopfheim
Baden-wüberg
South-africa

HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H.C. Wainwright & Co. 4th Annual Neuropsychiatry Conference

HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H.C. Wainwright & Co. 4th Annual Neuropsychiatry Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Germany
Munich
Bayern
Colorado
United-states
Colorado-convention-center
Denver
Anne-donohoe
Daniel-gehrlach
Sophia-bashford
Strategic-communications
Hc-wainwright-co

HMNC Brain Health Begins Phase 2 Study for Personalized

HMNC Brain Health Begins Phase 2 Study for Personalized
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Germany
Munich
Bayern
Sophia-bashford
Hans-eriksson
Anne-donohoe
Maximilian-doebler
Brain-health
Holding-gmb
Major-depressive-disorder
Chief-business-officer
Chief-medical-officer

HMNC Brain Health Begins Phase 2 Study for Personalized Treatment of Stress-Axis Related Major ...

MUNICH, Germany, June 20, 2023 (GLOBE NEWSWIRE) HMNC Brain Health (‘‘HMNC’’ or the ‘‘Company’’), a global clinical-stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced today

Germany
Munich
Bayern
Hans-eriksson
Sophia-bashford
Anne-donohoe
Maximilian-doebler
Holding-gmb
Brain-health
Major-depressive-disorder
Chief-business-officer
Chief-medical-officer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.